echanical-ventilation strategies that use lower end-inspiratory (plateau) airway pressures, lower tidal volumes (V T ), and higher positive end-expiratory pressures (PEEPs) -collectively termed lung-protective strategies -have been associated with survival benefits in randomized clinical trials involving patients with the acute respiratory distress syndrome (ARDS). [1] [2] [3] [4] The different components of lung protection in those strategies, such as lower V T , lower plateau pressure, and higher PEEP, can all reduce mechanical stresses on the lung, which are thought to induce ventilator-induced lung injury. [5] [6] [7] [8] [9] Clinical trials, however, have reported conflicting responses to the manipulation of separate components of lung protection, [10] [11] [12] [13] [14] and clinicians often face a dilemma when the optimization of one component negatively affects another (for instance, increasing PEEP may increase plateau pressure), with unknown net consequences. 15 To minimize ventilator-induced lung injury, most studies have scaled V T to predicted body weight to normalize V T to lung size. However, in patients with ARDS, the proportion of lung available for ventilation is markedly decreased, which is reflected by lower respiratory-system compliance (C RS ). 13, [16] [17] [18] Therefore, we hypothesized that normalizing V T to C RS and using the ratio as an index indicating the "functional" size of the lung would provide a better predictor of outcomes in patients with ARDS than V T alone. This ratio, termed the driving pressure (∆P = V T /C RS ), can be routinely calculated for patients who are not making inspiratory efforts as the plateau pressure minus PEEP.
To determine whether data from previous studies are consistent with this hypothesis, we combined individual data from patients involved in nine randomized trials comparing ventilation strategies in patients with ARDS. 1, 2, [10] [11] [12] [19] [20] [21] [22] We used both a standard risk analysis with multivariate adjustments and a multilevel mediation analysis 23, 24 and examined the extent to which a change in ∆P (or other variables) resulting from a change in ventilator settings could be statistically linked to effects on survival, independent of the underlying severity of the lung injury and of the specific lung-protection protocol.
Me thods

Derivation and Validation Cohorts
We derived a survival-prediction model with the use of data from a cohort of 336 patients with ARDS from four early randomized clinical trials testing various strategies of volume-limited ventilation. 1, [19] [20] [21] We next tested and refined this model with data from a validation cohort of 861 patients from a large, randomized trial 2 comparing lower versus higher V T values. Finally, we retested the model with data from a more recent validation cohort of 2365 patients with ARDS enrolled in four randomized trials comparing higher-PEEP versus lower-PEEP strategies 4, [10] [11] [12] 22 (Table 1, and  Tables S1 and S2 and Fig. S1 in the Supplementary Appendix, available with the full text of this article at NEJM.org).
Independent Variables and Outcomes
The primary outcome (the dependent variable) was survival in the hospital at 60 days (Cox survival model). Data from patients who were discharged home before day 60 were censored at day 60, with the patients considered to be alive at day 60.
The independent variables tested as predictors included treatment group (lung-protective [i.e., varying variables such as V T , PEEP, and plateau pressures with an intention to protect] vs. control assignment), characteristics of patients, baseline severity of illness (e.g., risk according to the Acute Physiology and Chronic Health Evaluation [APACHE] or Simplified Acute Physiology Score [SAPS] and the ratio of the partial pressure of arterial oxygen to the fraction of inspired oxygen [PaO 2 :FIO 2 ]), and ventilation variables (e.g., V T and plateau pressure) averaged over the first 24 hours after randomization (Table S3 in the Supplementary Appendix). In a separate analysis, we averaged individual ventilation data over the first 3 days and observed no predictive advantage of this approach (Tables S4, S5 , and S6 in the Supplementary Appendix). Patients who received pressure-support ventilation or had respiratory rates that were higher than the ventilator settings (suggesting the presence of ventilatory efforts) were excluded. Both conditions accounted for less than 3% of our sample. Barotrauma was defined as pneumothorax requiring chesttube drainage during the first 28 days after randomization.
backward stepwise multivariate analysis. Variables that were consistently found to be associated with survival with the use of both modeling procedures were included in the final derivation model. We adjusted all analyses for the trial variable (Fig. S2 in the Supplementary Appendix).
The derivation model (model 1) was subsequently tested in each of the validation cohorts, as well as in the combined data set. To show that the prognostic information provided by ∆P was independent of PEEP and plateau-pressure values, we resampled the combined data set (see Section III.3 in the Supplementary Appendix), producing subgroups of patients with matched mean levels for one variable (e.g., PEEP) but distinct mean levels for another ranking variable (e.g., driving pressure).
Mediation Analysis
To investigate whether ∆P was more than a baseline risk predictor, we conducted a mediation analysis, 24, 25 searching for key variables that could be linked to positive outcomes after randomization. When mediation analysis is applied to randomized controlled trials, the goal is to determine whether a specific variable, strongly affected by treatment-group assignment, has an effect on outcomes that explains in whole or in part the effects ; positive end-expiratory pressure (PEEP), 5 cm of water; and tidal volume (V T ), 2 ml per kilogram of predicted body weight. By normalizing relative risk in this way, we were able to compare the strength of the association of different variables with survival as the relative risk per se (using 1/relative risk when the relative risk was <1). For instance, in the combined analysis, ∆P had a stronger association with survival (relative risk, 1.4) than did PaO 2 :FIO 2 (1/relative risk = 1/0.87 = 1.15). Although it is not shown in the table, the variables day 1 plateau pressure, day 1 respiratory-system compliance, and day 1 mean airway pressure were tested before and after inclusion of ∆P in model 1 and showed no significant association with survival (see Section II.6, Table S8 , in the Supplementary Appendix). CI denotes confidence interval. † The risk of death was calculated according to the equations of the Acute Physiology and Chronic Health Evaluation (APACHE) II, APACHE III, or Simplified Acute Physiology Score (SAPS) II, depending on the trial. ‡ The P value is for the test of inclusion of the variable in the model in which the variables in model 1 plus the extra covariate in the line below were previously included. § The P value is for the test of inclusion of the variable in the model (the net contribution of the variable to predictive power in a likelihood ratio test) in which the variables in model 1 plus ∆P were previously included. 
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T h e ne w e ngl a nd jou r na l o f m e dicine resulting from treatment-group assignment. 24, 25 For the relevant fraction of the effect in which such a variable (the "mediator" in the model) is implicated, the correlation with outcomes must exceed that of treatment group, typically exhibiting an independent, dose-response relationship (i.e., larger mediator changes are associated with stronger survival effects). For example, in the lower-V T studies, we tested whether survival was better explained by specific ventilatory variables than by treatment group (the treatment group in these studies incorporated an intention-to-treat bundle including various recommendations, such as V T reduction, plateau-pressure limitation, and acidosis management). We tested four mediator candidates: V T , plateau pressure, PEEP, and ∆P. The first three variables were explicit targets in the protocols, whereas ∆P, which was a dependent variable in these studies, was the variable we hypothesized a priori to be the key mediator. Following standard procedures for mediation analysis, we examined each mediator candidate through a sequence of four logical tests, ultimately assessing whether variations in the mediator explained the mean benefit of the randomly assigned treatment group, as well as assessing the dose-response effect on outcomes. We used R software, version 2.10.1, with the R Package for Causal Mediation Analysis (R Project for Statistical Computing), 23, 24 in which a mediation proportion is estimated, indicating how much of the whole risk reduction in the treatment group can be explained by the indirect path in which treatment-group assignment drives a change in the mediator and the change in the mediator then affects the outcome (see the Supplementary Appendix). We calculated an average causal mediation effect, 24 which expressed the independent hazard (relative risk) associated with this indirect path. Other analyses were conducted with the use of SPSS software, version 20 (SPSS).
To avoid possible biases due to differences in the severity of the underlying respiratory disorder, we preadjusted all mediation models according to the baseline respiratory system tidal elastance (the reciprocal of tidal compliance). For the lower-V T trials, this calculation was not possible, because baseline data were frequently missing. Thus, we used the elastance ranks within each treatment group (calculated after randomization) for each trial, assuming that the systematic changes in ventilation parameters due to treatment-group assignment might affect absolute values of elastance but would not affect the ranking of individual elastance values within the respective study groups. In the Supplementary Appendix (Section II.4, Fig. S3 ), we present a sensitivity analysis addressing this assumption.
In addition to the covariates of model 1, we entered baseline respiratory system tidal elastance in all regression models used for the mediation analysis, a procedure that intrinsically filtered out the potential confounding caused by differences in the severity of underlying lung disease. Accordingly, the mediation analysis exclusively addressed the effect of variations in ∆P related to strategy -that is, variations in ∆P superimposed by changes in ventilator settings after randomization.
R esults
Building and Testing the Prediction Model
In univariate analyses in the derivation cohort, several significant associations were detected between independent predictor variables and survival (Table S3 in the Supplementary Appendix). Two baseline variables (risk according to APACHE or SAPS and arterial pH) and two ventilator variables (FIO 2 and ∆P) were significantly associated with survival after multivariate adjustment.
The test of this preliminary model in our first validation cohort showed that baseline PaO 2 :FIO 2 could replace the information associated with the FIO 2 variable (Table S7 in the Supplementary Appendix), with the advantage of being externally validated. 26 We also observed that age was a strong, independent predictor of survival even though it is a component of the APACHE score. After conservatively including the trial covariate, our final model included six variables ( 
Driving Pressure and Survival in ARDS
Independence of Information
Even though ∆P is mathematically linked to C RS and V T , no other ventilation variable conferred independent predictive information to any survival model when ∆P was already a covariate. In contrast, ∆P always conferred strong, nonredundant predictive information when it was included in models preadjusted for other ventilator variables (Table 1, models 2 and 3; and Table S8 in the Supplementary Appendix, models 2 through 5). This observation was consistent in the derivation, validation, and combined cohorts. Higher ∆P predicted lower survival consistently across trials (P = 0.13 for heterogeneity) (Fig. S4 in the Supplementary Appendix). Figure 1 shows that in the pooled sample (including 3562 patients), higher plateau pressures were observed in patients with higher ∆P or higher PEEP, but with different consequences (resampling A vs. B): higher mortality was noted only when higher plateau pressures were observed in patients with higher ∆Ps. Similarly, the protective effects of higher PEEP were noted only when there were associated decreases in ∆P (resampling B vs. C).
Risk Priority of ∆P
In addition, at constant levels of plateau pressure (Fig. S5 in the Supplementary Appendix), we observed that V T was a strong predictor of survival when normalized to C RS (i.e., ∆P) but not when normalized to predicted body weight. We also found a strong association between ∆P and survival even though all the ventilator settings that were used were lung-protective (relative risk of death, 1.36; 95% confidence interval [CI], 1.17 to 1.58; P<0.001). 2, 11 In contrast, further reductions in plateau pressures or V T below these thresholds (plateau pressures ≤30 cm of water and V T ≤7 ml per kilogram of predicted body weight) had no effect on survival (Fig. S6 in the Supplementary Appendix). Figure 2 shows the increase in the risk of death as a function of progressive percentiles of ∆P in the combined population. There was also an increase in the odds of pneumothorax requiring drainage as a function of progressive percentiles of ∆P but not of V T (Fig. S7 in the Supplementary Appendix).
Test of Mediation
After observing that ∆P was associated with outcomes in each study, we performed a multilevel mediation analysis 23 with the use of trial as a random effect, initially pooling the five V T studies and then pooling the four PEEP studies (Fig.  S8 through S11 in the Supplementary Appendix). A consistency analysis (Table S9 in the Supplementary Appendix) testing moderated mediation also suggested that there was consistency across trials.
Reductions in ∆P after randomization were significantly associated with better survival in both cohorts (step 2 of mediation analysis) (Fig.  S8 and S9 in the Supplementary Appendix), independently of baseline elastance of the respiratory system, and had similar effect sizes in both cohorts (relative risk for V T trials, 0.62; 95% CI, 0.52 to 0.74; relative risk for PEEP trials, 0.57; 95% CI, 0.42 to 0.72).
For the V T and PEEP trials, treatment-group assignment was an independent predictor of survival. Except for ∆P, however, no mediation candidate consistently passed through the stepwise mediation tests ( Fig. S10 and S11 in the Supplementary Appendix). V T per se was not a significant mediator in the V T trials (P = 0.68 for the average causal mediation effect), and PEEP was not a significant mediator in the PEEP trials (P = 0.50). In contrast, ∆P mediated 75% of the benefits due to treatment-group assignment in the V T trials (P = 0.004 for the average causal mediation effect) and 45% of these benefits in the PEEP trials (P = 0.001). This was enough to suppress the significance of the direct effect of the randomized treatment group, classically characterizing complete mediation.
Thus, although ∆P was not an explicit target, survival benefits in the V T trials were proportional to reductions in ∆P driven by treatment-group assignment rather than to reductions in V T (tested as a continuous variable). Similarly, the survival benefits observed in the PEEP trials occurred in relation to reductions in ∆P rather than in relation to numerical increments in PEEP.
Discussion
In trials of mechanical ventilation involving patients with ARDS, in which V T and PEEP were included as independent variables, the dependent quantity ∆P was the variable that was most strongly associated with survival. Although causality can be inferred only from direct controlled trials, we found, using a statistical approach that adjusted for the effect of underlying lung disease on the mechanical characteristics of the lung, that ∆P was a critical mediator of the benefits of various interventions. Our analyses indicated that reductions in V T or increases in PEEP driven by random treatment-group assignment were beneficial only if associated with decreases in ∆P. No other ventilation variable had such a mediating effect. We identified the striking correlations between . This scaling has a strong physiological basis. In patients with ARDS, C RS is directly related to functional lung size (the volume of aerated lung available for tidal ventilation). 17, 18 These observations suggest that the aerated lung in a patient with ARDS is not "stiff" but is small, with nearly normal specific compliance (compliance per unit of lung volume) in preserved areas.
The rationale underlying our mediation analysis was that ∆P was the surrogate for cyclic lung strain that was most accessible and easiest to calculate 27 ; ∆P is defined as the amount of cyclic parenchymal deformation imposed on ventilated, preserved lung units. We also postulated that cyclic strain predicts lung injury better than V T . Implicitly, we hypothesized that the functional lung size during disease is better quantified by C RS than by predicted body weight. Under such conditions, especially when C RS varies considerably among patients, cyclic strain, ventilator-induced lung injury, and survival should all be correlated with ∆P rather than with V T .
Although this mediation analysis cannot establish causality, experimental studies provide a plausible link between ∆P and ventilator-induced lung injury. Many studies suggest that cell and tissue damage are more closely related to the amplitude of cyclic stretch than to the maximal level of stretch -that is, lung tissue can undergo sustained stretching without damage. 5, 7, 8, [27] [28] [29] [30] Our study has a number of limitations. First, our conclusions are valid only for ventilation in which the patient is not making respiratory efforts. It is difficult to interpret ∆P in actively breathing patients. Second, we studied a relatively narrow range of variables. Thus, extrapolations to patients with plateau pressures greater than 40 cm of water, PEEPs less than 5 cm of water, or respiratory rates greater than 35 breaths per minute are not warranted. Finally, we did not directly estimate the cyclic gradient of pressures across the lung (transpulmonary ∆P), which is the probable effector of parenchymal injury. Because a large fraction of ∆P is typically applied to inflate the lung in patients with severe ARDS, ∆P was probably a reasonable surrogate for transpulmonary ∆P. However, this approach may not be relevant to patients with extremely low chestwall compliances. 22, 31 The Acute Respiratory Distress Syndrome Network (ARDSNet) trial 2 is often viewed as showing that low V T values per se decrease mortality from ARDS. However, our analyses suggest that the efficacy of this strategy is also critically dependent on other components of the lung-protective bundle (e.g., plateau-pressure limitation, respiratory-rate modification, and hypercapnia). For example, when low V T values were introduced into the lung, improved survival was observed only when large changes in ∆P (the dependent variable during volume control) were avoided.
Our findings might also explain why studies of higher PEEPs did not show consistent survival benefits 4, [10] [11] [12] ; PEEP increments might be protective only when the increased PEEP values result in a change in lung mechanics so that the same V T can be delivered with a lower ∆P. This hypoth- The combined cohort (with 1249 death events) was partitioned into 15 quantiles of ∆P, and the relative risk for each quantile was calculated in relation to the mean risk of the combined population (assumed to be 1). The mean risk and 95% confidence intervals (error bars) for each percentile were calculated after multivariate adjustment at the patient level (Cox proportional-hazards model) for the five covariates (trial, age, risk of death according to APACHE or SAPS, arterial pH at entry, and PaO 2 :FIO 2 at entry) specified in model 1. The gray zone represents the 95% confidence interval for the Cox regression (dashed line) across the whole population when ∆P is considered as a continuous variable. esis is consistent with recent physiological studies suggesting that the benefits of PEEP are found mainly in patients with greater lung recruitability, 15 with some harm reported when PEEP caused overdistention. 15, 32, 33 Well-known devastating effects of zero-PEEP ventilation 7, 8 have been related to progressive atelectasis, decreased lung compliance, and ultimately higher ∆P. 34 Finally, our work is a post hoc observational analysis. Clinical trials need to be designed in which ventilator changes are linked to achieve changes in ∆P, in order to determine whether our observations can be translated into changes that may be implemented at the bedside.
